Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT00132288 Completed - Diabetes Mellitus Clinical Trials

MY PALS: A Community-Based Physical Activity Support Program for Older Adults

Start date: May 2005
Phase: N/A
Study type: Interventional

This is a study of whether physical activity of older adults can be improved by linking primary care clinics serving older adults to a community-based program that provides motivational support, including peer counselors, for engaging in and maintaining moderate levels of physical activity. Health care providers at the participating study sites routinely assess and track diabetic patients' physical activity. In addition to this routine care, study volunteers are referred to a support program that has been modelled on the Active Choices Program. Changes in volunteers' levels of activity are measured at 3, 6, and 12 months.

NCT ID: NCT00131755 Completed - Clinical trials for Diabetes Mellitus, Type 1

Efficacy of Diazoxide in Type 1 Diabetes

Start date: February 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to find out if Diazoxide can partly retain insulin production in newly diagnosed type 1 diabetes patients.

NCT ID: NCT00131287 Completed - Clinical trials for Diabetes Mellitus, Type II

The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)

Start date: July 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.

NCT ID: NCT00129259 Completed - Clinical trials for Diabetes Mellitus, Type 1

Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes

AbATE
Start date: September 2005
Phase: Phase 2
Study type: Interventional

Anti-CD3 monoclonal antibody (a.k.a. hOKT3gamma1 [Ala-Ala],teplizumab, MGA031) is a humanized antibody that is commonly used to prevent organ rejection. The purpose of this study is determine whether anti-CD3 mAb treatment can halt the progression of newly diagnosed type 1 diabetes.

NCT ID: NCT00127634 Completed - Clinical trials for Diabetes Mellitus, Type 1

Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes

Start date: July 2005
Phase: Phase 3
Study type: Interventional

This is a phase 3, open-label, randomized study to evaluate the safety and efficacy of the Lilly/Alkermes inhaled insulin system compared to injected pre-meal insulin in non-smoking patients with type 1 diabetes. Patients will be treated for 24 months with a 2-month follow-up period.

NCT ID: NCT00127296 Completed - Clinical trials for Diabetes Mellitus, Type 2

Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

Start date: July 2005
Phase: Phase 1
Study type: Interventional

This trial is conducted in the United States of America (USA). The aim of this trial is to compare desired (target) with actual target amounts of insulin dispensed using NovoLog® Mix 70/30 FlexPen® and vial and syringe in subjects with type 2 diabetes mellitus. No insulin is administered in this trial - insulin is dispensed into an empty vial.

NCT ID: NCT00126126 Completed - Diabetes Mellitus Clinical Trials

Evidence Based Amputee Rehabilitation (EBAR) Program

EBAR
Start date: January 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if an evidence based exercise intervention improves the functional mobility of diabetic amputees (single lower leg amputation) who have already completed standard rehabilitation and prosthetic training.

NCT ID: NCT00123435 Completed - Obesity Clinical Trials

Veterans Walk for Health Study

VWH
Start date: July 2005
Phase: N/A
Study type: Interventional

The objective of this study is to determine whether a tailored web-based system for providing feedback on walking step-counts, in combination with regular nutrition counseling, can improve weight loss over nutrition counseling alone in patients with heart disease.

NCT ID: NCT00122421 Completed - Diabetes Mellitus Clinical Trials

The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients

Start date: June 2003
Phase: N/A
Study type: Interventional

The goal of this study is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Women's Hospital. This will be accomplished through pharmacist recommendations provided to primary care providers prior to routine scheduled office visits for diabetic patients.

NCT ID: NCT00121667 Completed - Clinical trials for Diabetes Mellitus, Type 2

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

Start date: August 2005
Phase: Phase 3
Study type: Interventional

The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone